Tag Archives: PhD; Father Kevin FitzGerald

Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board

Montreal, Canada, May 4, 2017 (Newswire.com) – Fortuna Fix Inc. (“Fortuna”), a private, clinical-stage biotech company, is aiming to be the first to eliminate the need for embryonic and fetal stem cells by using direct reprogramming of autologous cells to treat … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , | 1 Comment